Braslyn Ltd.'s Net Worth

$230 Million

Estimate Recalculated Jul 22, 2024 03:16PM EST

Who is Braslyn Ltd.?

Braslyn Ltd. has an estimated net worth of $230 Million. This is based on reported shares across multiple companies, which include Mirati Therapeutics, Inc., Tango Therapeutics, Inc., INSEEGO CORP., Esperion Therapeutics, Inc., Solid Biosciences Inc., and Pandion Therapeutics, Inc..

SEC CIK

Braslyn Ltd.'s CIK is 0001642355

Past Insider Trading and Trends

2017 was Braslyn Ltd.'s most active year for acquiring shares with 19 total transactions. Braslyn Ltd.'s most active month to acquire stocks was the month of December. 2020 was Braslyn Ltd.'s most active year for disposing of shares, totalling 43 transactions. Braslyn Ltd.'s most active month to dispose stocks was the month of September. 2017 saw Braslyn Ltd. paying a total of $68,267,805.02 for 8,636,936 shares, this is the most they've acquired in one year. In 2020 Braslyn Ltd. cashed out on 12,782,177 shares for a total of $228,777,517.36, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Mirati Therapeutics, Inc. (MRTX) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.86M
—
—
0
Jan 23
Form 4
—
0
$197.64
-$2,446,911.13
3.14M
Mar 9 - Mar 10
Form 4
—
0
$208.34
-$83,334,657.83
3.14M
Oct 28 - Oct 29
Form 4/A
—
0
$97.00
-$58,200,004.13
3.14M
Jun 12
Form 4
—
0
$69.00
-$41,399,836.79
3.14M
Jun 12
Form 4
—
0
$69.00
-$18,975,016.20
3.14M
Mar 1
Form 4
+9.74%
400K
$13.00
$5,200,000.00
4.51M
Nov 16
Form 4
+18.19%
267.97K
$7.86
$2,106,212.76
1.74M
Oct 3
Form 4
+1.70%
48.17K
$5.45
$262,327.75
2.88M
Jan 26
Form 4
+2.81%
77.53K
$5.35
$414,573.01
2.83M
Jan 23 - Jan 25
Form 4
+2.27%
61.16K
$5.46
$334,037.46
2.75M
Jan 18 - Jan 20
Form 4
+4.66%
119.89K
$5.50
$658,855.39
2.69M
Jan 12 - Jan 17
Form 4
+29.21%
581.87K
$5.60
$3,258,472.00
2.57M
Jan 6
Form 4
+23.33%
376.9K
$9.96
$3,752,417.06
1.99M
Jun 6 - Jun 7
Form 4
+4.25%
65.78K
$18.21
$1,197,905.89
1.62M
May 5 - May 6
Form 4
+0.22%
3.4K
$19.09
$64,906.00
1.55M
Mar 29
Form 4
+1.37%
20.85K
$19.36
$403,653.28
1.55M
Mar 24 - Mar 28
Form 4
+0.08%
1.17K
$19.34
$22,550.44
1.53M
Mar 18
Form 4
+32.67%
375.3K
—
—
1.52M
Mar 17
Form 4
+119.84%
626.19K
—
—
1.15M
Jan 15
Form 4
-100.00%
-522.50K
—
—
0
Jan 4
Form 3
—
0
—
—
0
No matching records found

Tango Therapeutics, Inc. (TNGX) Snapshot price: $12.68

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Esperion Therapeutics, Inc. (ESPR) Snapshot price: $2.67

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Solid Biosciences Inc. (SLDB) Snapshot price: $7.43

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Pandion Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.13M
$18.00
—
2.13M
Jul 21
Form 3
—
0
—
—
0
No matching records found